Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The effects of preventive interventions on cardiovascular autonomic neuropathy (CAN) remain unclear. We examined the effect of intensively treating traditional risk factors for CAN, including hyperglycemia, hypertension, and dyslipidemia, in individuals with type 2 diabetes (T2D) and high cardiovascular risk participating in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND METHODS: CAN was defined as heart rate variability indices below the fifth percentile of the normal distribution. Of 10,251 ACCORD participants, 71% (n = 7,275) had a CAN evaluation at study entry and at least once after randomization. The effects of intensive interventions on CAN were analyzed among these subjects through generalized linear mixed models. RESULTS: As compared with standard intervention, intensive glucose treatment reduced CAN risk by 16% (odds ratio [OR] 0.84, 95% CI 0.75–0.94, P = 0.003)—an effect driven by individuals without cardiovascular disease (CVD) at baseline (OR 0.73, 95% CI 0.63–0.85, P < 0.0001) rather than those with CVD (OR 1.10, 95% CI 0.91–1.34, P = 0.34) (Pinteraction = 0.001). Intensive blood pressure (BP) intervention decreased CAN risk by 25% (OR 0.75, 95% CI 0.63–0.89, P = 0.001), especially in patients ≥65 years old (OR 0.66, 95% CI 0.49–0.88, P = 0.005) (Pinteraction = 0.05). Fenofibrate did not have a significant effect on CAN (OR 0.91, 95% CI 0.78–1.07, P = 0.26). CONCLUSIONS: These data confirm a beneficial effect of intensive glycemic therapy and demonstrate, for the first time, a similar benefit of intensive BP control on CAN in T2D. A negative CVD history identifies T2D patients who especially benefit from intensive glycemic control for CAN prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High frequency (eg,10 kHz) spinal cord stimulation is a nonpharmacological approach that may be effective in persons with painful DPN that failed at least one medication, as suggested by a recent large RCT, leading to FDA approval in 2021 (Fig. 4).606,607”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [607]
Citations
Cites
Heart Rate Variability: Standards of Measurement, Physiological Interpretation, and Clinical Use
Electrophysiology, T. F. O. T. E. S. O. C. T. N. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.1043 · Cited by 17,159
Heart rate variability: Standards of measurement, physiological interpretation, and clinical use
Malik, M., Bigger, J. T., Camm, A. J., Kleiger, R. E., Malliani, A., Moss, A. J., & Schwartz, P. J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014868 · Cited by 15,289
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“CAN persisted after transition to the standard glycemic control targets, which suggests a “metabolic memory” phenomenon such as that demonstrated in prior cohorts and for other diabetes complications (7,18).”
BackgroundGlucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“(Intensified Multifactorial Intervention in Patients With Type 2 Diabetes and Microalbuminuria) trial demonstrated a 63% reduction in the rate of progression to CAN in individuals with type 2 diabetes (T2D) via intensive multifactorial interventions targetinghyperglycemia, hypertension, dyslipidemia, and lifestyle (10…”
BackgroundTesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 9×
“For this analysis, we defined CAN as present (1) or absent (0) at each timepoint during”
BackgroundMethodInfluentialSelf-citationSilverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citation12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gibbons, C. H., Giurini, J. M., Hilliard, M. E., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s012 · Cited by 207
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Callaghan, B. C., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s012 · Cited by 214
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Callaghan, B. C., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s012 · Cited by 176
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gibbons, C. H., Giurini, J. M., Hilliard, M. E., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s012 · Cited by 169
Chowdhury, M., Nevitt, S. J., Eleftheriadou, A., Kanagala, P., Esa, H., Cuthbertson, D. J., Tahrani, A. A., & Alam, U. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002480 · Cited by 125
Duque, A. P., Mediano, M. F. F., Lorenzo, A. D., & Rodrigues, L. F. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.855 · Cited by 114
Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management
Williams, S., Raheim, S. A., Khan, M. I., Rubab, U., Kanagala, P., Zhao, S. S., Worthington, A., Brown, E. E., & Alam, U. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.09.002 · Cited by 112
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
The conundrum of diabetic neuropathies—Past, present, and future
Ang, L. P., Mizokami‐Stout, K., Eid, S., Elafros, M. A., Callaghan, B. C., Feldman, E. L., & Pop‐Busui, R. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108334 · Cited by 66
Self-citationDiabetic neuropathy: Pathogenesis and evolving principles of management
Zaino, B., Goel, R., Devaragudi, S., Prakash, A., Vaghamashi, Y., Sethi, Y., Patel, N., & Kaka, N. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101582 · Cited by 63
Guan, H., Tian, J., Wang, Y., Niu, P., Zhang, Y., Zhang, Y., Fang, X., Miao, R., Yin, R., & Tong, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-01739-1 · Cited by 63
Cardiac autonomic neuropathy and risk of incident heart failure among adults with type 2 diabetes
Kazé, A. D., Yuyun, M. F., Erqou, S. A., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2432 · Cited by 49
Crabtree, T., Ogendo, J.-J., Vinogradova, Y., Gordon, J., & Idris, I. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2079495 · Cited by 38
Kazé, A. D., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.029814 · Cited by 35
Wang, P., Ma, X. M., Geng, K., Jiang, Z. Z., Yan, P. Y., & Xu, Y. (2022) · Phytotherapy Research · doi:10.1002/ptr.7572 · Cited by 31
Elafros, M. A., & Callaghan, B. C. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001291 · Cited by 31
Autonomic diabetic neuropathies: A brief overview
Pop‐Busui, R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110762 · Cited by 29
Self-citationBönhof, G. J., Herder, C., & Ziegler, D. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210412123740 · Cited by 29
Tang, Y., Ang, L. P., Jaiswal, M., Dillon, B. R., Esfandiari, N. H., Shah, H., Spino, C., Plunkett, C., Perkins, B. A., Pop‐Busui, R., et al. (2023) · Diabetes · doi:10.2337/db23-0247 · Cited by 25
Self-citationGlycemic Targets and Prevention of Complications
Tsushima, Y., & Galloway, N. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae776 · Cited by 21
Autonomic dysfunction and risk of severe hypoglycemia among individuals with type 2 diabetes
Kazé, A. D., Yuyun, M. F., Ahima, R. S., Rickels, M. R., & Echouffo-Tcheugui, J. B. (2022) · JCI Insight · doi:10.1172/jci.insight.156334 · Cited by 19
The Epidemiology of Diabetic Neuropathy
Hansen, C. S., Määttä, L. L., Andersen, S. T., & Charles, M. H. (2023) · Contemporary Diabetes · doi:10.1007/978-3-031-15613-7_2 · Cited by 17
Kundu, S., Ghosh, S., & Sahu, B. D. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09579-2 · Cited by 15
Huang, Q., Nan, W., He, B., Xing, Z., & Peng, Z. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02622-x · Cited by 14
Irlik, K., Aldosari, H., Hendel, M., Kwiendacz, H., Piaśnik, J., Kulpa, J., Ignacy, P., Boczek, S., Herba, M., Kegler, K., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15578 · Cited by 13
Kazé, A. D., Yuyun, M. F., Ahima, R. S., Sachdeva, M. M., & Echouffo-Tcheugui, J. B. (2022) · Diabetic Medicine · doi:10.1111/dme.14857 · Cited by 13
Brock, C., Andersen, H., Alibegovic, A. C., Andersen, S. R. D., Andreasen, L., Charles, M., Christensen, D. H., Drewes, A. M., Gall, M.-A., Gylfadottir, S. S., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112010 · Cited by 12
Self-citationZhou, Z., Huang, Y., Zhuang, X., Guo, Y., Xie, P., Xiong, Z., Liu, M., Zhang, W., Zhong, J., Li, Y., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.034626 · Cited by 11
May, S. M., Chiang, E., Reyes, A., Martir, G., Patel, A., Karmali, S. N., Patel, S., West, S. J., del Arroyo, A. G., Gourine, A. V., et al. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100299 · Cited by 11
Menduni, M., D’Amato, C., Leoni, M., Izzo, V., Staltari, M., Greco, C., Abbatepassero, A., Seminara, G., D’Ippolito, I., Lauro, D., et al. (2022) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12510 · Cited by 10
Lee, S. J., Kim, C. H., Jeong, S. J., Yun, J., Won, J. C., Lee, J. H., Park, I. B., Lee, C. W., Kwon, H., & Park, T. S. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e154 · Cited by 9
Cardiac autonomic dysfunction and risk of incident stroke among adults with type 2 diabetes
Kazé, A. D., Yuyun, M. F., Fonarow, G. C., & Echouffo-Tcheugui, J. B. (2022) · European Stroke Journal · doi:10.1177/23969873221127108 · Cited by 9
Goh, J. K., & Koh, L. (2023) · Diabetology International · doi:10.1007/s13340-023-00629-x · Cited by 9
Schaarup, J. R., Bjerg, L., Hansen, C. S., Grove, E. L., Andersen, S. T., Vistisen, D., Brage, S., Sandbæk, A., & Witte, D. R. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16566 · Cited by 8
Genetic Variants Influence the Development of Diabetic Neuropathy
Hajdú, N., Rácz, R., Tordai, D. Z., Békeffy, M. Z., Vági, O. E., Istenes, I., Körei, A. E., Kempler, P., & Putz, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126429 · Cited by 8
Cardoso, C. R. L., de Oliveira, V. A. G., Leite, N. C., & Salles, G. F. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110232 · Cited by 8
SDNN24 Estimation from Semi-Continuous HR Measures
Morelli, D., Rossi, A., Bartoloni, L., Cairo, M., & Clifton, D. A. (2021) · Sensors · doi:10.3390/s21041463 · Cited by 8
Intensive Glycemic Therapy in Type 2 Diabetes Patients With Cardiac Autonomic Dysfunction
Huang, Y., Xie, P., Zhang, S., Liu, M., Huang, R., Xiong, Z., Zhong, X., Lin, Y., Zhou, Z., Zhang, W., et al. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.03.020 · Cited by 6
Rooney, M. R., Norby, F. L., Soliman, E. Z., Chen, L. Y., Selvin, E., & Echouffo-Tcheugui, J. B. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108903 · Cited by 6
Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02856-9 · Cited by 5
“…a similar modifiable risk factor profile, including glucose and blood pressure management, was recently reported in a large cohort of participants with T2D in the ACCORD trial who were phenotyped for CAN using the same ECG-derived HRV indices, suggesting common CAN pathways in both T1D and T2D [6].”
Self-citationZhou, H., Huang, Y., Xie, P., Zhang, S., Liu, M., Xiong, Z., Huang, R., Xu, X., Li, M., Zhou, Z., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.035788 · Cited by 5
Lai, Y., Huang, C., Chiu, W.-C., Cheng, B., Lin, T.-Y., Chiang, H.-C., & Lu, C. (2024) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2024.102946 · Cited by 5
Wang, J., Xu, Z., Lv, K., Ye, Y., Luo, D., Wan, L., Zhou, F., Yu, A., Wang, S., Liu, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.864008 · Cited by 5
Aso, Y. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13565 · Cited by 5
Bekenova, N., Vochshenkova, T. A., Aitkaliyev, A., Imankulova, B., Turgumbayeva, Z., Kassiyeva, B., & Benberin, V. V. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21121653 · Cited by 3
Marinho, L. L., Ribeiro, M. L., Lawler, P. R., Iatan, I., Godoy, L. C., Rached, F. H., & Maranhão, R. C. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01292-0 · Cited by 3
A diabeteses cardiovascularis autonóm neuropathia klinikuma, diagnosztikája és terápiája
Kempler, P., & Körei, A. E. (2024) · Orvosi Hetilap · doi:10.1556/650.2024.33027 · Cited by 2
Xin, Y., Peng, N., Xin, C.-Y., Liao, J.-R., Hu, X., Dong, Y., & Zhang, X. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i8.108671 · Cited by 2
Diabetic neuropathy: Current issues in diagnosis and prevention
Spallone, V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00016-6 · Cited by 2
Zhang, W., Huang, Y., Zhou, Z., Xie, P., Zhuang, X., Jiang, J., & Liao, X. (2024) · Endocrine · doi:10.1007/s12020-024-03728-0 · Cited by 2
Treatment Options for Diabetic Neuropathy: Insights from the Romanian Neuropathy Guidelines
Nica, A. E., Parliteanu, O. A., Claudia, S., Dobjanschi, C. G., Rusu, E., & Radulian, G. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1009813 · Cited by 3
Pop‐Busui, R., Rosin, S. P., Butera, N. M., Krause-Steinrauf, H. J., Assi, H. A., Garg, R., Inzucchi, S. E., Katona, A. M., McGill, J. B., Mudaliar, S. R. D., et al. (2025) · Diabetes Care · doi:10.2337/dc25-1087 · Cited by 2
Self-citationCardiovascular Autonomic Neuropathy
Ang, L. P., & Pop‐Busui, R. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_12 · Cited by 2
Self-citationRetinopathy, Neuropathy, and Foot Care
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch19 · Cited by 1
Complicações Neurológicas da Diabetes Mellitus
Borges, C., Costa, A., Guimarães, P., Pires, V., & Mendes, M. (2026) · Sinapse · doi:10.46531/sinapse/ar/132/2026 · Cited by 1
Dina, H., Heltty, H., & Zahalim, Z. (2024) · INDONESIAN JOURNAL OF HEALTH SCIENCES RESEARCH AND DEVELOPMENT (IJHSRD) · doi:10.36566/ijhsrd/vol6.iss1/207 · Cited by 1
Schaarup, J. R., Bjerg, L., Hansen, C. S., Andersen, S. T., van Greevenbroek, M. M. J., Schram, M. T., de Galan, B. E., Stehouwer, C. D. A., & Witte, D. R. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-004995 · Cited by 1
A neuropathia diabetica genetikai aspektusai
Putz, Z., Tordai, D. Z., Hajdú, N., Vági, O. E., Kempler, M., Békeffy, M. Z., Körei, A. E., Istenes, I., & Kempler, P. (2022) · Diabetologia Hungarica · doi:10.24121/dh.2022.4
Genetikai tényezők szerepe a diabéteszes neuropátia kialakulásában
Hajdú, N., Tordai, D. Z., Rácz, R., Ludvig, Z., Vági, O. E., Békeffy, M. Z., Körei, A. E., Istenes, I., Kempler, P., & Putz, Z. (2025) · Diabetologia Hungarica · doi:10.24121/dh.2025.17
Protocolo de diagnóstico e tratamento da Neuropatia Diabética
VIEIRA, J. N. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Sabonienė, G. (2024) · Lithuanian University of Health Sciences
Okoro, C. E., Zhou, T. L., Kallen, C., Koster, A., Sutedja, N. A., Berendschot, T. T. J. M., de Galan, B. E., Eussen, S. J. P. M., Schram, M. T., & Kroon, A. A. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113212
Choe, H. J., Koo, B. K., Hong, Y., Kim, N. H., Moon, J. S., Lee, Y., Cho, H., Kwak, S. H., Lim, S. K., Kim, D.-L., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113388
Early autonomic neuropathy in prediabetes: an overlooked driver of cardiometabolic risk
Concepción‐Zavaleta, M. J., Fuentes‐Mendoza, J. M., Urteaga, L. A. C., Castillo-Balderas, S. A., Morón-Siguas, J. C., Paz‐Ibarra, J., & Aldave, J. E. Q. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2696292
Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates
Anagnostopoulou, V., Travlos, C. K., Marinho, L. L., Mavrakanas, T. A., Ferreira, J. P., & Sharma, A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71230
Fridman, V. (2026) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001744
Metadata
- Authors
- Tang, Y., Shah, H., Bueno Junior, C. R., Sun, X., Mitri, J., Sambataro, M., Sambado, L., Gerstein, H. C., Fonseca, V., Doria, A., & Pop-Busui, R.
- Affiliations
- Joslin Diabetes Center (US)
- Research Division, Joslin Diabetes Center, Boston, MA
- Ca' Foncello Hospital (IT)
- Population Health Research Institute (CA)
- Tulane University (US)
- Division of Metabolism, Endocrinology & Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
- Corresponding author
- Doria, Alessandro
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-11-03
- Volume
- 44
- Issue
- 1
- Pages
- 164-173
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7783932
- OpenAlex
- W3095717227
- Cited by
- 60
- References
- 35
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 11 · 2023: 10 · 2022: 14 · 2021: 6
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Iacocca Foundation (Mary K. Iacocca Fellowship)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK107956-01, U01 DK119083)
- JDRF (DK36836)
- National Heart, Lung, and Blood Institute (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, IAA-Y1-HC-1010)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- cardiac autonomic neuropathy, type 2 diabetes, tight glycemic control, intensive blood pressure control, fenofibrate, heart rate variability, ACCORD trial, cardiovascular risk, hypertension, dyslipidemia, older adults
- MeSH terms
- Aged, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Fenofibrate, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.